Investors Want Venture Funds Kept Out Of Theranos Suit
Investors who purchased Theranos Inc. stocks through venture funds on Wednesday urged a California federal court not to rope the funds into the litigation, arguing there's no risk of double recovery...To view the full article, register now.
Already a subscriber? Click here to view full article